Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

South Korea · Delayed Price · Currency is KRW

5,140.00

+80.00 (1.58%)

At close: Aug 3, 2026

Sinil Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	82,183	80,564	89,440	89,135	80,007	61,754
Revenue Growth	-4.35%	-9.93%	0.34%	11.41%	29.56%	0.52%
Gross Profit	35,198	33,437	40,666	37,570	35,645	24,441
Operating Income	6,747	7,386	15,222	13,991	13,656	7,982
Net Income	6,951	7,531	14,301	13,641	12,157	6,679
Earnings Per Share	601.36	651.49	1237.13	1179.82	1092.89	594.11
EPS Growth	-45.06%	-47.34%	4.86%	7.95%	83.95%	-11.37%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	38,294	39,214	33,713	23,419	23,354	20,870
Total Debt	248.64	283.19	432.68	544.13	139.48	273.22
Net Cash (Debt)	38,045	38,931	33,281	22,875	23,214	20,597
Net Cash Growth	8.19%	16.98%	45.49%	-1.46%	12.71%	45.04%
Net Cash Per Share	3291.21	3367.83	2879.07	1978.43	2086.88	1832.18

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	9,449	11,589	22,689	15,154	13,688	11,163
Capital Expenditures	-3,853	-3,145	-10,362	-13,604	-10,351	-3,343
Free Cash Flow	5,595	8,444	12,327	1,551	3,336	7,820
Free Cash Flow Growth	-48.03%	-31.50%	694.85%	-53.52%	-57.34%	245.93%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	42.83%	41.50%	45.47%	42.15%	44.55%	39.58%
Operating Margin	8.21%	9.17%	17.02%	15.70%	17.07%	12.93%
Pretax Margin	9.44%	10.67%	18.49%	16.78%	18.30%	13.51%
Profit Margin	8.46%	9.35%	15.99%	15.30%	15.20%	10.81%
FCF Margin	6.81%	10.48%	13.78%	1.74%	4.17%	12.66%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	8.41	9.17	5.12	6.43	7.97	19.21
P/FCF Ratio	10.29	8.18	5.93	56.56	29.03	16.41
PS Ratio	0.70	0.86	0.82	0.98	1.21	2.08